Gender Male
LinkedIn View on LinkedIn
Wes Gail joined Arboretum Ventures in 2014 as an Analyst.
Wes is responsible for assessing potential investment opportunities and providing support to Arboretum’s portfolio companies.
Previously, Wes was a Healthcare Investment Banking Analyst at Deutsche Bank Securities. In this role, Wes worked on a number of deals in the medical technology
and pharmaceutical sectors, including the sale of Aqua Pharmaceuticals to Almirall for up to $400 million.
